ArticleMolecular diagnosis & therapy2014

Impact of specific KRAS mutation in exon 2 on clinical outcome of chemotherapy- and radiotherapy-treated colorectal adenocarcinoma patients.

Krzysztof Roszkowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.